当前位置:首页 - 行情中心 - 特宝生物(688278) - 财务分析 - 利润表

特宝生物

(688278)

  

流通市值:344.15亿  总市值:344.15亿
流通股本:4.07亿   总股本:4.07亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入1,510,615,117.77673,345,118.052,817,158,242.241,954,701,664.76
  营业收入1,510,615,117.77673,345,118.052,817,158,242.241,954,701,664.76
二、营业总成本1,025,083,005.41460,732,480.51,881,373,801.841,299,117,116.43
  营业成本106,031,437.9545,964,557.21183,510,989.26129,931,313.61
  税金及附加7,638,447.313,447,135.6913,734,839.569,607,337.31
  销售费用598,906,025.59279,057,633.191,113,261,379.3777,951,300.68
  管理费用140,327,604.7367,371,305.32278,335,096.01190,145,563.47
  研发费用174,802,367.1466,748,824.3294,706,975.17193,341,950.18
  财务费用-2,622,877.31-1,856,975.21-2,175,477.46-1,860,348.82
  其中:利息费用379,937.93117,669.02452,682.01357,362.06
  其中:利息收入2,896,353.291,959,565.872,940,756.942,329,579.68
三、其他经营收益
  加:公允价值变动收益590,535.2340,457.03882,868.151,293,715.4
  加:投资收益1,873,297.191,354,606.794,053,394.382,283,996.64
  资产处置收益14,090.210,027.6865,368.1545,498.08
  信用减值损失(新)986,036.52779,811.54-3,608,425.93-547,467.37
  其他收益8,153,402.565,167,341.6833,558,945.9514,285,614.94
四、营业利润497,149,474.06219,964,882.27970,736,591.1672,945,906.02
  加:营业外收入598,955.94229,195.89682,275.72641,065.38
  减:营业外支出21,476,326.2810,977,89140,392,302.7927,835,028.99
五、利润总额476,272,103.72209,216,187.16931,026,564.03645,751,942.41
  减:所得税费用48,377,992.5127,087,270.27103,424,330.1491,602,724.6
六、净利润427,894,111.21182,128,916.89827,602,233.89554,149,217.81
(一)按经营持续性分类
  持续经营净利润427,894,111.21182,128,916.89827,602,233.89554,149,217.81
(二)按所有权归属分类
  归属于母公司股东的净利润427,894,111.21182,128,916.89827,602,233.89554,149,217.81
  扣除非经常损益后的净利润431,339,041.81188,596,287.25826,964,773.08580,667,315.81
七、每股收益
  (一)基本每股收益1.050.452.031.36
  (二)稀释每股收益1.050.452.031.36
九、综合收益总额427,894,111.21182,128,916.89827,602,233.89554,149,217.81
  归属于母公司股东的综合收益总额427,894,111.21182,128,916.89827,602,233.89554,149,217.81
公告日期2025-08-212025-04-232025-03-282024-10-25
审计意见(境内)标准无保留意见
TOP↑